Back
Grand Canyon Education Vs. Longboard Pharmaceuticals Industry Stock Comparison
Buy
60
LOPE
Grand Canyon Education
Last Price:
143.28
Seasonality Move:
0.36%
Buy
94
LBPH
Longboard Pharmaceuticals
Last Price:
34.89
Seasonality Move:
0.54%
Buy
60
Grand Canyon Education (LOPE)
is a Buy
Is Grand Canyon Education a Buy, Sell or Hold?
- The current Grand Canyon Education [LOPE] share price is $143.31. The Score for LOPE is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- LOPE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
94
Longboard Pharmaceuticals (LBPH)
is a Buy
Is Longboard Pharmaceuticals a Buy, Sell or Hold?
- The current Longboard Pharmaceuticals [LBPH] share price is $34.87. The Score for LBPH is 94, which is 88% above its historic median score of 50, and infers lower risk than normal.
- LBPH is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
LOPE Stock Price Chart
What is Grand Canyon Education's stock price today?
-
The Grand Canyon Education share price today is $143.31
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LOPE is experiencing slight selling pressure.
LBPH Stock Price Chart
What is Longboard Pharmaceuticals's stock price today?
-
The Longboard Pharmaceuticals share price today is $34.87
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
LOPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.18 | Buy |
| Relative Strength Index (14 RSI): | 60.39 | Buy |
| Chaikin Money Flow: | -68600 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (136.34 - 143.04) | Buy |
| Bollinger Bands (100): | (130.8 - 141.98) | Buy |
LBPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.22 | Buy |
| Relative Strength Index (14 RSI): | 86.65 | Buy |
| Chaikin Money Flow: | 484372 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.64 - 26.62) | Buy |
| Bollinger Bands (100): | (17.72 - 23.42) | Buy |
LOPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 139.42 | Buy |
| 20-day SMA: | 138.78 | Buy |
| 50-day SMA: | 140.23 | Buy |
| 200-day SMA: | 132.27 | Buy |
| 8-day EMA: | 140.48 | Buy |
| 20-day EMA: | 139.67 | Buy |
| 50-day EMA: | 139.04 | Buy |
| 200-day EMA: | 131.46 | Buy |
LBPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.37 | Buy |
| 20-day SMA: | 22.43 | Buy |
| 50-day SMA: | 21.05 | Buy |
| 200-day SMA: | 15.33 | Buy |
| 8-day EMA: | 28.7 | Buy |
| 20-day EMA: | 24.43 | Buy |
| 50-day EMA: | 21.77 | Buy |
| 200-day EMA: | 16.75 | Buy |
Grand Canyon Education Earnings Growth & LOPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.22 per share, an increase this year of $0.86 per share, and an increase next year of $0.85 per share.
Longboard Pharmaceuticals Earnings Growth & LBPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.23 per share, an increase this year of $0.56 per share, and a decrease next year of $0.55 per share.
Grand Canyon Education Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Longboard Pharmaceuticals Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||